Nexgel (NXGL) files Form 144 to sell 16,000 shares

Rhea-AI Filing Summary

Nexgel, Inc. (NXGL) filed a Form 144 reporting a proposed sale of 16,000 common shares with an aggregate market value of $40,000.00. The shares were originally acquired on 10/15/2019 as compensation from the issuer. The filing lists approximately 8,067,580 shares outstanding and names The Charles Schwab Corporation as the broker with an approximate sale date of 10/02/2025 on NASDAQ. The filer also reported a prior sale of 4,000 shares on 08/28/2025 for gross proceeds of $9,896.00. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.

Positive

• None.

Negative

• Insider sale planned: Proposed sale of 16,000 shares for $40,000, indicating insider liquidity.
• Recent dispositions: Prior sale of 4,000 shares on 08/28/2025 for $9,896.

Insights

Insider Trading Specialist

Insider plans to sell 16,000 NXGL shares, previously granted as compensation.

The filing shows the shares were granted as compensation on 10/15/2019 and the proposed sale is for an aggregate market value of $40,000 with an approximate sale date of 10/02/2025.

This is a notification under Rule 144 and indicates the holder is seeking to sell restricted or controlled shares through The Charles Schwab Corporation. The prior sale of 4,000 shares on 08/28/2025 for $9,896 shows some recent liquidity activity by the same account.

Equity Analyst

Planned sale equals ~0.20% of outstanding NXGL shares.

The proposed 16,000-share sale against 8,067,580 outstanding shares represents roughly 0.20% of the float by simple ratio, indicating the transaction is small relative to total shares outstanding.

Because this filing is a standard Rule 144 notice and contains no operational or financial disclosures, it is a limited signal about company performance but is relevant to short-term share supply.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON	THE CHARLES SCHWAB CORPORATION 3000 Schwab Way Westlake TX 76262	16000	40000.00	8067580	10/02/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
COMMON	10/15/2019	COMPENSATION	ISSUER			16000	10/15/2019	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
ADAM R LEVY C/O 2150 Cabot Blvd West, Suite B Langhorne PA 19047	COMMON	08/28/2025	4000	9896.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the NXGL Form 144 report?

The Form 144 reports a proposed sale of 16,000 common shares of Nexgel (NXGL) with an aggregate market value of $40,000, approximate sale date 10/02/2025.

Who is the broker listed for the proposed NXGL sale?

The broker named in the filing is The Charles Schwab Corporation located at 3000 Schwab Way, Westlake, TX.

When were the shares being sold originally acquired?

The shares were acquired on 10/15/2019 as compensation from the issuer.

Has the filer sold NXGL shares recently?

Yes. The filing discloses a prior sale of 4,000 shares on 08/28/2025 for gross proceeds of $9,896.00.

How large is the proposed sale relative to NXGL's outstanding shares?

The proposed 16,000-share sale vs. 8,067,580 shares outstanding equals roughly 0.20% of outstanding shares by simple ratio.